MDM2 and colorectal carcinoma: Of note, despite similar level of increase in p53 by the MDM2 inhibitor in both PTEN-/- and PTEN+/+ CRC cells, the fold increase in the p53 level to its basal level was significantly higher in PTEN-/- CRC cells (Figure 3G-H).